SCHEMBL4776140

SCHEMBL4776140

CS(=O)(=O)N(Cc1cccc(Cl)c1Cl)c1ccc(COCc2ccc(C(F)(F)F)nc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
NR1H2 P55055 3/20 0.36
NR1H3 Q13133 3/20 0.36
PTGER1 P34995 1/20 0.36
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35
TRPM8 Q7Z2W7 4/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
GRM2 Q14416 2/20 0.34
MAPT P10636 1/20 0.33
RORC P51449 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767929 0.88 GAA (0.42) GAALMNATRPM8MEN1KMT2A
SCHEMBL4772347 0.85 GAA (0.37) GAANR1H2NR1H3PTGER1LMNA
SCHEMBL4767863 0.82 GAA (0.61) GAALMNAMEN1KMT2ASMN1; SMN2
SCHEMBL4772351 0.78 P2RX7 (0.43) GAA
SCHEMBL4775349 0.78 LMNA (0.41) GAALMNAPOLBHTTSMN1; SMN2
SCHEMBL5571164 0.77 GAA (0.44) GAANR1H2NR1H3LMNAPOLB
SCHEMBL4776754 0.77 GAA (0.47) GAALMNASMN1; SMN2
SCHEMBL4776659 0.77 GAA (0.45) GAALMNAPOLBSMN1; SMN2MAPT
SCHEMBL4770843 0.77 LMNA (0.36) GAANR1H2NR1H3LMNAPOLB
SCHEMBL4772420 0.77 GAA (0.37) GAANR1H2NR1H3PTGER1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 GAA 466/4885NR1H2 2527/4885NR1H3 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.